A novel homozygous GALC variant has been associated with Krabbe disease in a consanguineous family
Krabbe disease (KD) or globoid cell leukodystrophy is an autosomal recessive lysosomal storage disorder involving the white matter of the peripheral and the central nervous systems. It is caused by a deficiency of galactocerebrosidase enzyme activity. The most common manifestation is the classical early onset KD that leads to patient’s loss before the age of 2. Herein, we report the evaluation of a consanguineous family with three affected children manifesting severe neurological findings that ended with death before the age of 2, in an attempt to provide genetic diagnosis to the family. One of the children underwent detailed physical and neurological examinations, including brain magnetic resonance imaging (MRI) and scalp electroencephalography (EEG) evaluations. GALC genetic testing on this child enabled identification of a novel homozygous variant (NM_000153.3: c.1394C>T; p.(Thr465Ile)), which confirmed diagnosis as KD. Familial segregation of this variant was performed by PCR amplification and Sanger sequencing that revealed the parents as heterozygous carriers. We believe this novel GALC variant will not only help in genetic counseling to this family but will also aid in identification of future KD cases.
KeywordsKrabbe disease GALC Genetic analysis Novel variation Consanguinity
The authors are grateful to the patients and their relatives for their participation in this study.
We would like to acknowledge Advanced Genomics and Bioinformatics Research Center (IGBAM), TUBITAK MAM-GMBE, for kindly providing variant frequency data of 1182 exome sequenced individuals from Turkey with varying disorders, which was used as a population control set towards the evaluation of the novel GALC variant. We would also like to acknowledge Sedef Iskit, PhD, for technical assistance towards the construction of the artwork.
Feyza Nur Tuncer (FNT) and Sibel Aylin Ugur Iseri (SAUI) were involved in genetic evaluation of the recruited family members, data acquisition, and analyses. FNT has written the original draft, which subsequently was edited by SAUI. Mahmut Demir (MD), Meryem Karaca (MK), and Mustafa Calik (MC) were involved in clinical evaluations of the patients, interview with the available family members and in commenting of several drafts of the manuscript. Zuhal Yapici (ZY) took role both in the evaluation of the patients’ MRI and writing the clinical findings in the main draft. MC mentored the study.
This work was supported by the grant of The Scientific and Technology Research Council of Turkey (TUBITAK) Project Number: 113S331. Biobanking support was provided by Istanbul Development Agency (ISTKA) Project Number: TR10/15/YNK/0093.
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Accordingly, informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare that they have no conflicts of interest.
- 3.Africa L, Margollicci M, Salvatore S, Shalbafan B, Peruzzi L, Togha M, Sorrentino V, Federico A (2017) Compound heterozygosity in the GALC gene in a late onset Iranian patient with spastic paraparesis, peripheral neuropathy and leukoencephalopathy. Neurol Sci 38(9):1721–1722. https://doi.org/10.1007/s10072-017-2986-6 CrossRefGoogle Scholar
- 7.Duffner PK, Barczykowski A, Jalal K, Yan L, Kay DM, Carter RL (2011) Early infantile Krabbe disease: results of the World-Wide Krabbe Registry. Pediatr Neurol 45(3):141–148. https://doi.org/10.1016/j.pediatrneurol.2011.05.007 CrossRefGoogle Scholar
- 9.Tomás J, Durães J, Lacerda L, Macário MC (2015) Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation. BMJ Case Rep. https://doi:10.1136/bcr-2015-210625Google Scholar
- 11.Kwon JM, Matern D, Kurtzberg J, Wrabetz L, Gelb MH, Wenger DA, Ficicioglu C, Waldman AT, Burton BK, Hopkins PV, Orsini JJ (2018) Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease. Orphanet J Rare Dis 13:30. https://doi.org/10.1186/s13023-018-0766-x CrossRefGoogle Scholar
- 12.Saavedra-Matiz CA, Luzi P, Nichols M, Orsini JJ, Caggana M, Wenger DA (2016) Expression of individual mutations and haplotypes in the galactocerebrosidase gene identified by the newborn screening program in New York State and in confirmed cases of Krabbe’s disease. J Neurosci Res 94(11):1076–1083CrossRefGoogle Scholar
- 13.Puckett RL, Orsini JJ, Pastores GM, Wang RY, Chang R, Saavedra-Matiz CA, Torres PA, Zeng B, Caggana M, Lorey F, Abdenur JE (2012) Krabbe disease: clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards. Mol Genet Metab 105(1):126–131. https://doi.org/10.1016/j.ymgme.2011.10.010 CrossRefGoogle Scholar
- 16.Abdelhalim AN, Alberico RA, Barczykowski AL, Duffner PK (2014) Patterns of magnetic resonance imaging abnormalities in symptomatic patients with Krabbe disease correspond to phenotype. Pediatr Neurol 50(2):127–134. https://doi.org/10.1016/j.pediatrneurol.2013.10.001 CrossRefGoogle Scholar
- 20.David RB (2009) Clinical pediatric neurology. Third Edition New York, NYGoogle Scholar
- 25.Gucev Z, Tasic V. Compound galactosylceramıdase gene (GALC) heterozygosity in a boy with infantile Krabbe disease (KD) (2015) Pril (Makedon Akad Nauk Umet Odd Med Nauki) 36(3):99–101. 10.1515/prilozi-2015-0084Google Scholar
- 26.Tuncer FN, Gormez Z, Calik M, Altiokka Uzun G, Sagiroglu MS, Yuceturk B, Yuksel B, Baykan B, Bebek N, Iscan A, Ugur Iseri SA, Ozbek U (2015) A clinical variant in SCN1A inherited from a mosaic father cosegregates with a novel variant to cause Dravet syndrome in a consanguineous family. Epilepsy Res 113:5–10. https://doi.org/10.1016/j.eplepsyres.2015.02.020 CrossRefGoogle Scholar
- 27.Hossain MA, Takanobu Otomo T, Saito S, Ohno K, Sakuraba H, Hamada Y et al (2014) Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form. Gene 534:144–154. https://doi.org/10.1016/j.gene.2013.11.003 CrossRefGoogle Scholar
- 28.Vargiami E, Papathanasiou E, Batzios S, Kyriazi M, Dimitriou E, Anastasiou A, Michelakakis H, Giese AK, Zafeiriou DI (2016) Neuroradiological, neurophysiological and molecular findings in infantile Krabbe disease: two case reports. Balkan J Med Genet 19(1):85–90. https://doi.org/10.1515/bjmg-2016-0011 CrossRefGoogle Scholar
- 32.Kabadayı A (2016) İstatistiklerle Aile, Türkiye İstatistik Kurumu (TUIK) (updated May 10, 2017). Available at: http://www.tuik.gov.tr/HbPrint.do?id=24646. Accessed June 01, 2018Google Scholar
- 33.Bongarzone ER, Escolar ML, Gray SJ, Kafri T, Vite CH, Sands MS (2016) Insights into the pathogenesis and treatment of Krabbe disease. Pediatr Endocrinol Rev 13:689–696Google Scholar